Live Breaking News & Updates on Panras|Page 2

Stay updated with breaking news from Panras. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Balancing Quality of Life: Adjuvant Therapy Toxicity in Melanoma Adjuvant Immunotherapy

A panel of oncology experts explores the intricate balance between maintaining quality of life and managing toxicity in adjuvant immunotherapy for melanoma. ....

Treatment Approach , Evolving Treatment Strategies , Metastatic Melanoma , Adjuvant Therapy Toxicity , Melanoma Adjuvant , Adjuvant Melanoma , Biomarker Testing , Wild Type ,

Case 1: 55-Year-Old Male with Stage IIIB Melanoma Developing Immunotherapy-Induced Diabetes

Afreen Shariff, MD introduces case 1 involving a 55-year-old male with Stage IIIB melanoma who develops immunotherapy-induced diabetes. ....

Afreen Shariff , Treatment Approach , Evolving Treatment Strategies , Metastatic Melanoma , Year Old Male , Adjuvant Melanoma , Biomarker Testing , Wild Type ,

Exploring Immunotherapy Resistance: Impact on Treatment Decisions in Melanoma

Nikhil Khushalani, MD, examines immunotherapy resistance in melanoma treatment, providing valuable insights into navigating challenges and its impact on treatment decisions. ....

Nikhil Khushalani , Treatment Approach , Evolving Treatment Strategies , Metastatic Melanoma , Treatment Decisions , Adjuvant Melanoma , Biomarker Testing , Wild Type ,

The Current Landscape Surrounding Adjuvant Therapy in Melanoma

Nikhil Khushalani, MD, provides a thorough exploration of the current treatment landscape in adjuvant therapy for melanoma, presenting insights into advancing strategies and developments in the field, while also discussing key findings from the Checkmate-238 and KEYNOTE-054 trials. ....

Nikhil Khushalani , Treatment Approach , Evolving Treatment Strategies , Metastatic Melanoma , Current Landscape Surrounding Adjuvant Therapy , Adjuvant Melanoma , Biomarker Testing , Wild Type ,

Combination Immunotherapy Strategies for Melanoma in the Adjuvant Setting

Nikhil Khushalani, MD, delves into the role of combination immunotherapy strategies for melanoma in the adjuvant setting, providing insights into the specific details and outcomes of the IMMUNED trial. ....

Nikhil Khushalani , Treatment Approach , Evolving Treatment Strategies , Metastatic Melanoma , Adjuvant Melanoma , Biomarker Testing , Wild Type ,